首页 | 本学科首页   官方微博 | 高级检索  
     

早期应用肺表面活性物质治疗新生儿呼吸窘迫综合征疗效观察
引用本文:潘春梅,柯桦,陈若珊,唐渊. 早期应用肺表面活性物质治疗新生儿呼吸窘迫综合征疗效观察[J]. 河北医学, 2007, 13(3): 314-316
作者姓名:潘春梅  柯桦  陈若珊  唐渊
作者单位:广东省茂名市人民医院儿科,广东,茂名,525000;广东省茂名市人民医院儿科,广东,茂名,525000;广东省茂名市人民医院儿科,广东,茂名,525000;广东省茂名市人民医院儿科,广东,茂名,525000
摘    要:目的:探讨肺表面活性物质(PS)早期给药对极低出生体重儿呼吸窘迫综合征(NRDS)疗效的观察.方法:对19例患NRDS的极低出生体重儿给予PS治疗并同时进行临床对照实验.结果:NRDS患儿给药后24h PO2/FiO2较用药前明显改善,差异显著(P<0.05),呼吸机参数(除PEEP外)明显下降,差异有显著性意义(P<0.05).结论:对于极低出生体重儿NRDS,早期给予PS治疗可明显改善近期预后,提高存活率.

关 键 词:肺表面活性物质  呼吸窘迫综合征  极低出生体重
文章编号:1006-6233(2007)03-0314-03

Observing the Effect of Pulmonary Surfactant Early Bringing Down Neonatal Respiratry Distress Syndrome
PAN Chun-mei,KE Hua,CHEN Ruo-shan,et al. Observing the Effect of Pulmonary Surfactant Early Bringing Down Neonatal Respiratry Distress Syndrome[J]. Hebei Medicine, 2007, 13(3): 314-316
Authors:PAN Chun-mei  KE Hua  CHEN Ruo-shan  et al
Abstract:Objective: To explorei effect of pulmonary surfactant(PS) in the treatment of neonatal respiratry dstress syndrome(NRDS) in early phase.Method:19 examples low birth weight infants with NRDS were treated with pulmonary surfactant in this controlled clinical trail.Result:After given PS 24 hours,the PO2/FiO2 and parameter of respirator utilization ascended significantly,there were significant difference(P<0.05).Conclusion: The strategy of surfactant treatment in early phase can significantly improve the survival of very low birth weight infants with NRDS.
Keywords:Pulmonary Surfactant  Neonatal respiratory distress syndrome  Born very low birth infant
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号